Advances in Lung Cancer Treatment Using Nanomedicines.

Carcinoma of the lungs is among the most menacing forms of malignancy and has a poor prognosis, with a low overall survival rate due to delayed detection and ineffectiveness of conventional therapy. Therefore, drug delivery strategies that may overcome undesired damage to healthy cells, boost therapeutic efficacy, and act as imaging tools are currently gaining much attention. Advances in material science have resulted in unique nanoscale-based theranostic agents, which provide renewed hope for patients suffering from lung cancer.

Importance of photophosphatidylserine and Tim-3 in photoimmunotherapy.

Natural killer (NK) cells help regulate autoimmune reactions, but overactivation causes harm. A Tim-3 receptor is an immune checkpoint that prevents overactivation. Its malfunction is related to autoimmune diseases and is mediated by phosphorylation of Tim-3 and other ligands.